Breeze Meds vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi beats Breeze Meds overall, scoring 7.7/10 vs 7.3/10. Breeze Meds is more affordable at $199/mo vs $299/mo. Choose Breeze Meds for users who want a straightforward compounded glp-1 program wi. Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side comparison of Breeze Meds and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
Breeze Meds
#29 of 40Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.
Visit Breeze MedsMEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | Breeze Meds | MEDVi |
|---|---|---|
| Our Score | 7.3/10 | 7.7/10 |
| Starting Price | $199/mo | $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a straightforward compounded GLP-1 program with fast shipping | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #29 | #21 |
Pros & Cons Compared
Breeze Meds
Pros
- +No subscription required — order on demand without recurring billing commitments
- +Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
- +FSA/HSA eligible for those with health savings accounts
- +Discreet packaging on all shipments
Cons
- −Very limited independent reviews and unclear company structure — legitimacy is hard to verify
- −Oral options at $299-399/mo are significantly more expensive than injectable alternatives
- −Not available in all 50 states — varies by provider licensure in your state
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out Breeze Meds with a score of 7.7/10 vs 7.3/10. If budget is your priority, Breeze Meds starts at $199/mo compared to MEDVi's $299/mo. Choose Breeze Meds if you want: users who want a straightforward compounded glp-1 program with fast shipping. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.